Jordan Toutounchian holds a Ph.D. in Pharmaceutical Sciences and has helped build and integrate automation scale-up efforts at two previous biotech startups before joining Enveda where he currently leads the Platform Biology group leveraging his expertise in disease biology, assay development, and high-throughput automation. He has spent years leading project teams across a variety of therapeutic areas including cardiovascular, metabolic, and oncology and is well-versed in designing, implementing and developing novel high-throughput assays to help identify and advance numerous small molecules from concept to IND-enabling studies.